• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCoronavirus

The omicron subvariant now dominating the U.S. is ‘the worst version of the virus that we’ve seen’

By
Erin Prater
Erin Prater
Down Arrow Button Icon
By
Erin Prater
Erin Prater
Down Arrow Button Icon
July 5, 2022, 1:23 PM ET
Commuters ride a subway in New York City on June 30. New Omicron subvariant BA.5 is estimated to have caused nearly 54% of COVID infections in the U.S. last week.
Commuters ride a subway in New York City on June 30. New Omicron subvariant BA.5 is estimated to have caused nearly 54% of COVID infections in the U.S. last week.Jeenah Moon—Bloomberg/Getty Images

New immune-evading Omicron subvariant BA.5 is now dominant in the U.S.—and previous heavy hitter “stealth Omicron” is now a shadow of its former self, according to federal health data released Tuesday.

BA.5 is estimated to have caused nearly 54% of COVID infections in the U.S. last week, according to data from the U.S. Centers for Disease Control and Prevention. Along with twin variant BA.4, it swept South Africa this spring thanks to its ability to evade immunity from both prior infection and vaccination.

The week before that, the two variants combined made up slightly more than half of U.S. cases. But last week, BA.5 accomplished the same feat alone, without the help of BA.4, which came in third at 16.5%.

The BA.2.12.1 variant, dominant until mid-June, came in second last week, accounting for a little over a quarter of cases. And so-called stealth Omicron, BA.2, nicknamed for its ability to evade detection on PCR tests, came in fourth, making up less than 3% of cases.

“The Omicron subvariant BA.5 is the worst version of the virus that we’ve seen,” Dr. Eric Topol, a professor of molecular medicine at Scripps Research and founder and director of the Scripps Research Translational Institute, wrote last week, before the latest numbers, but as the subvariant was well on its way to becoming dominant in the U.S.

“It takes immune escape, already extensive, to the next level, and, as a function of that, enhanced transmissibility,” well beyond what has been seen before, he wrote.

The jury is still out on whether current vaccines hold up against BA.5. But given that vaccines were 15% less effective against Omicron than they were against the Delta variant, even with a booster, “it would not be at all surprising to me to see further decline of protection against hospitalizations and deaths,” Topol wrote.

BA.4 and BA.5 were first detected in the U.S. in late March, as Fortune previously reported. The variants, discovered in South Africa, quickly took hold in the country in April and May despite the fact that almost all South Africans had been vaccinated or previously had COVID by that point.

The pair of variants are also quickly establishing themselves globally. But their rise is often masked, because in many countries, it’s occurring at the same time as a decline in BA.2 infections, Topol wrote. This can lead to the appearance of a sustained wave when, in reality, dual waves are present—the first from an older version of Omicron, and the second from BA.4/BA.5.

A recent study out of South Africa found that those who had been previously infected with Omicron but not vaccinated experienced a nearly eightfold drop in neutralizing antibodies when exposed to BA.4 and BA.5. Those who had been vaccinated and previously infected with Omicron saw a milder threefold decrease. 

Alex Sigal, a professor at the Africa Health Research Institute in South Africa, told Fortune in May that symptoms of the new subvariants are similar to typical Omicron symptoms, which include fever, loss of smell, and malaise. 

“I haven’t seen early symptoms of respiratory distress, the major COVID-specific symptom that makes this disease so dangerous,” he said. “It doesn’t feel nice, but there’s less chance of dying.”

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Erin Prater
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

AImental health
Chatbots are ‘constantly validating everything’ even when you’re suicidal. New research measures how dangerous AI psychosis really is
By Catherina GioinoMarch 7, 2026
10 hours ago
adams
CommentaryVaccines
Trump’s former Surgeon General: voters widely support vaccine access and want Washington to focus elsewhere
By Jerome AdamsMarch 7, 2026
11 hours ago
PoliticsImmigration
Emergency services were called by staff at ICE’s largest detention facility almost once a day for five months straight
By The Associated Press, Michael Biesecker, Ryan J. Foley and Morgan LeeMarch 6, 2026
1 day ago
HealthDietary Supplements
Cheapest Meal Delivery Services of 2026: Easy Meals on a Budget
By Christina SnyderMarch 6, 2026
1 day ago
Stressed Gen Z pharmacy worker
SuccessCareers
Gen Z graduates who majored in ‘AI-proof’ careers like pharmacy, biology, and education are making less than $50,000 after graduation
By Emma BurleighMarch 6, 2026
1 day ago
HealthDietary Supplements
 7 Best Protein Powders for Muscle Gain (2026: Fitness Expert Reviewed
By Emily PharesMarch 6, 2026
1 day ago

Most Popular

placeholder alt text
Success
Gen Z graduates who majored in ‘AI-proof’ careers like pharmacy, biology, and education are making less than $50,000 after graduation
By Emma BurleighMarch 6, 2026
1 day ago
placeholder alt text
AI
Anthropic just mapped out which jobs AI could potentially replace. A 'Great Recession for white-collar workers' is absolutely possible
By Jake AngeloMarch 6, 2026
1 day ago
placeholder alt text
AI
Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AI
By Marco Quiroz-GutierrezMarch 6, 2026
1 day ago
placeholder alt text
Economy
The Treasury may need to borrow an extra $1.6 trillion to cover the hole left by tariff ruling and pay a further $400 billion in debt interest
By Eleanor PringleMarch 6, 2026
1 day ago
placeholder alt text
AI
Nobel laureate Joe Stiglitz says not only can AI take your job, it’ll make the ‘tech bro’ class richer while doing so
By Catherina GioinoMarch 6, 2026
23 hours ago
placeholder alt text
Arts & Entertainment
Gen Z is hacking the exorbitant costs of live events by ditching Coachella and opting for something actually affordable. Meet Breakaway
By Sydney LakeMarch 7, 2026
12 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.